Preclinical Profile and Characterization of the Hepatitis C Virus NS3 Protease Inhibitor Asunaprevir (BMS-650032)Fiona McPhee, Paul M. Scola, Michael Sinz et al.|Antimicrobial Agents and Chemotherapy|2012Cited by 186
The Discovery of Asunaprevir (BMS-650032), An Orally Efficacious NS3 Protease Inhibitor for the Treatment of Hepatitis C Virus InfectionPaul M. Scola, Jialong Zhu, Li‐Qiang Sun et al.|Journal of Medicinal Chemistry|2014Cited by 112
Discovery and Early Clinical Evaluation of BMS-605339, a Potent and Orally Efficacious Tripeptidic Acylsulfonamide NS3 Protease Inhibitor for the Treatment of Hepatitis C Virus InfectionPaul M. Scola, Fiona McPhee, Alan Xiangdong Wang et al.|Journal of Medicinal Chemistry|2014Cited by 69
Discovery of a Potent Acyclic, Tripeptidic, Acyl Sulfonamide Inhibitor of Hepatitis C Virus NS3 Protease as a Back-up to Asunaprevir with the Potential for Once-Daily DosingLi‐Qiang Sun, William Warner, Eric Mull et al.|Journal of Medicinal Chemistry|2016Cited by 31
CCDC 984481: Experimental Crystal Structure DeterminationPaul M. Scola, Fiona McPhee, Alan Xiangdong Wang et al.|The Cambridge Structural Database|2014Cited by 0